The co-founders and management team of NRC Pharmaceutical Joint Stock Company announce that the Board of Directors has passed a resolution to establish a strategic partnership with Ladophar Joint Stock Company. This collaboration aims to optimize and develop pharmaceutical products, enhance service quality, and expand market reach. NRC will coordinate in research and development of new products and share technology. Both parties plan to implement several joint projects, facilitating resource and experience sharing within the pharmaceutical sector. This resolution is aimed at strengthening NRC’s market position in healthcare and increasing value for its shareholders.
Leave a Reply